Unknown PHASE2 INTERVENTIONAL 4-arm NCT03684772

Topical Ionic Contra-Viral Therapy in Actinic Keratosis

A Phase 2, Randomized, Double Blind, Vehicle Controlled, Parallel Group Study to Explore the Efficacy, Pharmacodynamics and Safety of Topical Ionic Contra-Viral Therapy (ICVT) Comprised of Digoxin and Furosemide in Actinic Keratosis

Sponsor: Maruho Co., Ltd.

Conditions Actinic Keratosis

Interventions Digoxin Topical Gel Furosemide Topical Gel ICVT Topical Gel Vehicle Topical Gel

Updated 8 times since 2018 Last updated: Apr 29, 2019 Started: Oct 22, 2018 Primary completion: Sep 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Actinic Keratosis, this trial is ongoing. The trial is conducted by Maruho Co., Ltd. and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE2
Jul 2019 — Jan 2021 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Jun 2019 — Jul 2019 [monthly]

Recruiting PHASE2
Dec 2018 — Jun 2019 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Oct 2018 — Dec 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maruho Co., Ltd.

Data source: Maruho Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leiden, Netherlands